Bio Developments

DSM to Supply Cancer Drug for Eisai

DSM to Supply Cancer Drug for Eisai

By Dan Stanton

Eisai says its US supply agreement with DSM offers an alternate manufacturing facility and ensures a strengthened supply line.

Chinese CRO Partnerships Focus on Bioavailability, PK/PD Analysis

Chinese CRO Partnerships Focus on Bioavailability, PK/PD Analysis

By Zachary Brennan

Contract drug developer Particle Sciences has recently chosen China-based CRO Crystal Pharmatech to analyse the bioavailability and material properties of its developing compounds, and the collaboration may turn into a joint venture.

This weeks movers and shakers in the pharma world

People on the Move: Jobs in Pharma

By Dan Stanton

In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals.

Follow us

Products

View more

Webinars